No abstract

No abstract

Patients with moderate-to-severe Crohn's disease who were treated with infliximab plus azathioprine or infliximab monotherapy were more likely to have a corticosteroid-free clinical remission than those receiving azathioprine monotherapy. (ClinicalTrials.gov number, NCT00094458.)

No abstract

hepatitis B infection interferon probably exerts its beneficial effect through the immune system, in chronic non-A non-B infection the interferon acts directly on the virus infected hepatocytes.These initial results are encouraging, and longer term study of these patients is being undertaken to see whether the histological picture of the liver improves in parallel to biochemical values and also whether the improvement persists after interferon has been discontinued. Preliminary studies suggest